Key takeaways
- CoQ10 at 100–300 mg/day improved outcomes in the Q-SYMBIO trial of heart-failure patients (Grade B evidence).
- Migraine prevention: multiple controlled trials show meaningful reductions in frequency at 100–300 mg/day (Grade B).
- Statin-associated muscle pain: evidence is mixed and Grade C — some trials show benefit, others show no difference versus placebo.
- General energy or athletic performance in healthy, replete individuals: Grade D — no reliable evidence of benefit.
- Ubiquinol form absorbs significantly better than standard ubiquinone; always take with a fat-containing meal.
What the evidence says
- Heart failure adjunct — improves symptoms and reduces major cardiovascular events in clinical HFB
- Migraine prevention — reduces frequency of episodes at 100–300 mg/dayB
- Statin-associated muscle pain — may reduce myalgia in some patients on statinsC
- General energy or athletic performance boost in healthy individualsD
What it is
CoQ10 — coenzyme Q10, also called ubiquinone — is a fat-soluble compound found in virtually every cell of the body, with highest concentrations in the heart, liver, kidneys and skeletal muscle. It plays a central role in the mitochondrial electron transport chain, the machinery that generates ATP (cellular energy), and acts as a potent antioxidant protecting cell membranes from oxidative stress.
The body synthesises CoQ10 naturally, but production declines with age and is significantly reduced by statin medications, which block the same biochemical pathway (the mevalonate pathway) that produces both cholesterol and CoQ10. This is the primary pharmacological rationale for CoQ10 supplementation in statin users — though, as the evidence shows, the clinical story is more nuanced than the marketing suggests.
As a supplement, CoQ10 comes in two main forms: ubiquinone (the oxidised form, standard in most capsules) and ubiquinol (the reduced, active form). Ubiquinol absorbs meaningfully better in humans, particularly in older adults — research suggests roughly 2–4-fold greater bioavailability, so if you are going to spend money on CoQ10, ubiquinol is the smarter choice.
Does it work? The evidence
Heart failure adjunct — Grade B. The strongest evidence for CoQ10 comes from cardiovascular medicine. The Q-SYMBIO trial, a multicentre randomised controlled trial published in JACC Heart Failure, found that 300 mg/day of CoQ10 significantly reduced major cardiovascular events and all-cause mortality in patients with severe heart failure compared to placebo over two years. This is meaningful, specific clinical data, not a vague wellness claim. It is also important context: these are patients with established disease under medical supervision — not healthy adults looking for an energy edge.
Migraine prevention — Grade B. Multiple controlled trials have investigated CoQ10 at 100–300 mg/day for episodic migraine. The evidence is moderately consistent: controlled trials have reported reductions in attack frequency of roughly 30–50% versus placebo. A randomised, double-blind trial published in Neurology (Sándor et al., 2005) found 300 mg/day of CoQ10 superior to placebo for reducing migraine frequency. Several neurological guidelines now list CoQ10 as a reasonable preventive option alongside magnesium and riboflavin. If you suffer from frequent migraines and prefer to explore non-pharmaceutical preventives, this is one of the better-evidenced options available without a prescription.
Statin-associated muscle pain — Grade C (mixed). Statins reduce endogenous CoQ10 synthesis, leading to a plausible rationale that supplementation might reduce statin-induced myalgia. Some trials support this; others do not. The evidence is genuinely mixed, with no consistent signal across trials. That said, given CoQ10's excellent safety profile, many GPs consider a trial reasonable for patients who are symptomatic on statins and reluctant to discontinue them. This is a conversation to have with your prescribing doctor, not a self-experiment.
General energy or athletic performance — Grade D. Here is where the marketing runs far ahead of the science. The appeal is intuitive — CoQ10 is involved in mitochondrial energy production, so surely more CoQ10 means more energy? In healthy, well-nourished individuals with normal endogenous CoQ10 levels, supplementation does not meaningfully increase energy production, VO₂max, or athletic performance in controlled trials. If you are healthy and eating a balanced diet, your mitochondria are not CoQ10-limited. Save your money for supplements with actual performance evidence — creatine being the most obvious example.
How to take it
For general use, 100–200 mg/day with a fat-containing meal is the standard starting point. Ubiquinol capsules at this dose represent the best value for absorption. Higher doses (up to 300 mg/day) are used in clinical migraine and heart-failure contexts — split across two meals (e.g. 100 mg breakfast and 100–200 mg lunch) to maintain steadier plasma levels and reduce the chance of GI discomfort.
Take it in the morning or at lunch, not in the evening — mild insomnia has been reported at higher doses when taken late in the day. Food is non-negotiable: CoQ10 is fat-soluble and absorption from a fasted, fat-free state is poor.
There is no established "loading" protocol for CoQ10. Plasma levels rise gradually over two to four weeks of consistent dosing. Give it at least eight weeks before deciding whether it is doing anything useful for you.
Who should take it — and who should not
Consider CoQ10 if you: are on a statin and experiencing muscle pain (discuss with your GP first); have a confirmed diagnosis of heart failure and your cardiologist is open to adjunct supplementation; suffer from frequent migraines and want to try an evidence-based non-pharmacological option; or are over 50 and interested in supporting mitochondrial health as endogenous synthesis declines.
Skip it if you: are a healthy adult hoping for a general energy boost or athletic performance gain — the evidence simply does not support this. You will get far more from dialling in your training, sleep, and nutrition. If you want performance support that is actually backed by strong evidence, start with creatine, omega-3 fish oil, or vitamin D if you are deficient.
Do not take it if you are on warfarin or another anticoagulant without medical clearance — the CoQ10–warfarin interaction is real and may reduce warfarin's anticoagulant effect, lowering INR and reducing clot-prevention. Pregnant and breastfeeding women should avoid it due to insufficient safety data. Under-18s should also avoid supplementation without GP advice.
Safety and interactions
CoQ10 has an excellent safety profile in the doses used in research. The most common side effects are mild and GI-related — nausea, loose stools, or stomach discomfort — particularly at higher doses or on an empty stomach. Taking it with food resolves this in most cases.
The primary clinically significant interaction is with warfarin. CoQ10 shares structural similarities with vitamin K and may reduce the anticoagulant effect of warfarin, lowering INR and reducing clot-prevention — monitor INR closely and inform your doctor. If you are on any anticoagulant, inform your prescribing doctor before starting.
At standard doses (100–300 mg/day), no serious adverse events have been reported in trials. Long-term safety data from the Q-SYMBIO and migraine literature are reassuring.
General information, not medical advice — check with a GP or pharmacist before starting, especially if pregnant, breastfeeding, under 18, or on medication.
How to buy it well
Not all CoQ10 supplements are equal. Key things to look for:
- Ubiquinol over ubiquinone where budget allows — superior absorption, particularly in adults over 40.
- Third-party tested: look for Informed-Sport certification (relevant if you are a tested athlete), or at minimum a brand that publishes independent Certificate of Analysis (CoA) results for heavy-metal and contaminant testing. This matters more for longevity-oriented supplements taken long-term.
- Dose transparency: the label should clearly state the amount of CoQ10 per capsule as ubiquinol or ubiquinone — not buried in a proprietary blend.
- Avoid cheap ubiquinone powder products with no quality certification. Absorption is the rate-limiting factor with CoQ10, and poor-quality bulk powder at a low price is effectively no CoQ10 at all.
Reputable brands offering third-party tested ubiquinol include those used in clinical trials — Kaneka QH® is the form of ubiquinol with the most research backing and is used in several published trials. Look for this designation on the label.
The verdict
CoQ10 is Situational — a Grade B supplement with genuinely useful applications in specific populations (heart failure adjunct, migraine prevention, statin myalgia trial) and no meaningful value for everyone else. It is not an energy supplement. It will not improve your gym performance. But if you are in one of the populations with real evidence behind it, it is well tolerated, reasonably priced in ubiquinol form, and worth a structured trial under appropriate medical oversight.
Supplements are roughly 5% of the result — a well-built training programme, consistent nutrition, and quality sleep do the other 95%. If you want to stop guessing and start making real progress, book a free consultation with a Lift Republic coach or take the free Blueprint quiz to find out exactly what your body needs.
Supplements are about 5% of the result. A coach gets the other 95% right.
Book a free consultationSafety & interactions
Generally well tolerated. Mild side effects include GI upset (nausea, diarrhoea) and occasionally insomnia at higher doses — take morning/noon if sleep disruption occurs. Warfarin interaction is the primary serious flag: CoQ10 has structural similarity to vitamin K and may reduce warfarin's anticoagulant effect, lowering INR and reducing clot-prevention — monitor INR closely and inform your doctor. Do not self-supplement if you are on anticoagulation therapy without medical oversight.
Avoid / check first if: On warfarin or other anticoagulants — CoQ10 may reduce warfarin's anticoagulant effect, lowering INR; consult your GP before starting. Pregnant or breastfeeding — insufficient safety data. Under 18 — insufficient safety data; consult a GP.
General information, not medical advice. Check with a GP or pharmacist before starting a supplement — especially if you are pregnant, breastfeeding, under 18, or taking any medication.
Sources & further reading
- Q-SYMBIO trial — CoQ10 in chronic heart failure (JACC Heart Failure) — JACC Heart Failure / PubMed
- Sándor et al. (2005) — CoQ10 RCT for migraine prevention (Neurology) — Neurology / PubMed
- Examine — Coenzyme Q10 (CoQ10) research summary — Examine
Citations are provided for transparency. This is general information, not medical advice — always consult a qualified professional about your own circumstances.